EDGAR Filing Documents for 9999999995-17-000220

Form EFFECT - Notice of Effectiveness:

SEC Accession No. 9999999995-17-000220

Accepted

2017-01-27 00:15:12

Documents

Effectiveness Date

2017-01-26

Registration Form

S-1

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	EFFECT
1		primary_doc.xml	EFFECT	595
	Complete submission text file	9999999995-17-000220.txt		1698

Mailing Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138

Business Address 1030 MASSACHUSETTS AVE. CAMBRIDGE MA 02138 857-259-3840

Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)